IDEA Pharma | From R&D to RxD

The 2026 China Pharmaceutical Innovation & Invention Index is live. See the full results at https://lnkd.in/eirJ_5J8 At the heart of the Innovation & Invention Index is a simple but revealing question: If two pharmaceutical companies were given the same molecule at an early stage, which would be better able to develop it and successfully bring it to market? The 2026 Index captures an industry increasingly moving beyond scale and fast-follower development towards differentiated innovation, stronger value realization and greater global impact. Congratulations to Hengrui Pharma Sinobiopharma, Inc. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Innovent Biologics Akeso Biopharma RemeGen荣昌生物 Simcere Pharmaceutical Group CSPC Pharmaceutical Group 3SBio Inc. Kelun-Biotech Zai Lab Haisco Pharmaceutical Group Co., Ltd

The 2026 China Pharmaceutical Innovation & Invention Index is live. Download the report to see the full company profiles and detailed top 30 ranking. At the heart of the Innovation & Invention Index is a simple but revealing question: If two pharmaceutical companies were given the same molecule at an early stage, which would be better able to develop it and successfully bring it to market? The 2026 Index captures an industry increasingly moving beyond scale and fast-follower development towards differentiated innovation, stronger value realization and greater global impact.

Biotech Disruptive Pioneers Award - 2027 - Call for Entries Open Be recognized along with other great biotech success stories and showcase how your science and technology could revolutionize medicine. The entrance criteria for consideration are one of the following three categories: Platform Pioneer – companies building technologies capable of generating multiple future medicines Disease Challenger – companies tackling diseases considered difficult, neglected or previously untreatable Modality Disruptor – companies pioneering new therapeutic modalities Entrants will be judged by an independent panel and shortlisted with winners being announced at the global Pharmaceutical Innovation and Invention Index launch in May 2027.

Strategic Advisory for Biotech Biotech companies face a series of high-impact decisions that determine whether an innovative asset becomes a commercial success. From defining a compelling market position, to selecting the optimal development pathway, to building commercial readiness, IDEA Pharma provides strategic guidance at every stage of the journey. Our integrated approach combines scientific, clinical, regulatory and commercial expertise to help biotech companies make better decisions, reduce uncertainty and maximise long-term asset value. Find out more at: https://lnkd.in/gi5np94M

Biotech Decision Intelligence Most biotech value is created - or lost - long before commercialization Critical early decisions around indication selection, differentiation, development sequencing, positioning, and market strategy shape not only clinical success, but also valuation, partnership potential, investor confidence, and long-term commercial impact. We provide integrated strategic support spanning early positioning, indication prioritization, path-to-market strategy, and lifecycle assessment with decisions grounded in pre-clinical and clinical science as well as commercial opportunity. Find out more at: https://lnkd.in/gi5np94M

Positioning Matters – from IDEA Pharma In Pharmaceutical Positioning, the challenge is to find the perfect combination of what the medical environment needs (even if your audience doesn’t realize it yet) and how your product can deliver this better than any other out there. Download the Positioning Matters Whitepaper to learn: - What do you believe your drug does that goes above and beyond the status quo? Why is it special and can make a difference? - How do you want the world to think and talk about it? - Embrace prototype mentality, improvise and iterate with the unanticipated, in ways that create and articulate new value - Unlock your product’s potential with IDEA Pharma’s approach to positioning and path to market strategy